Myasthenia gravis in the elderly: Is it different?

Annals of the New York Academy of Sciences

Volumn 1132, Issue , 2008, Pages 238-243

  Aarli, Johan A ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b NONE   (Norway)

Author keywords

Late onset; Myasthenia gravis; Thymectomy; Thymus; Titin antibodies

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; HLA A2 ANTIGEN;

CATARACTOGENESIS; CLINICAL FEATURE; CONFERENCE PAPER; GERIATRIC PATIENT; HUMAN; MYASTHENIA GRAVIS; QUALITATIVE ANALYSIS; RETINA MACULA DEGENERATION; THYMECTOMY; THYMOMA;

EID: 45249092352     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1405.040     Document Type: Conference Paper

References (36)

1. Compston, D.A.S. et al. 1980. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 103 : 579 601.
2. Saruhan-Direskeneli, G. et al. 2006. HLA-DQ polymorphism in Turkish patients with myasthenia gravis. Hum. Immunol. 67 : 352 358.
3. Somnier, F.E., N. Keiding & O.B. Paulson. 1991. Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey. Arch. Neurol. 48 : 733 739.
4. Aarli, J.A. et al. 2003. Myasthenia gravis in individuals over 40. Ann. N. Y. Acad. Sci. 998 : 1 8.
5. Evoli, A. et al. 2001. Clinical characteristics and prognosis of myasthenia gravis in older people. J. Am. Geriatr. Soc. 49 : 1257 1258.
6. Fraisse, T. et al. 2007. Myasthenia gravis in the elderly: diagnosis, comorbidity and course. Presse Med. 36 : 1 9.
7. Ishii, W. et al. 2007. Comparison of the histological and immunohistochemical features of the thymus in young- and elderly-onset myasthenia gravis without thymoma. J. Clin. Neurosci. 14 : 110 115.
8. Van den Bosch, W., I. Leenders & P. Mulder. 1999. Topographic anatomy of the eyelids, and the effects of sex and age. Br. J. Ophthalmol. 83 : 347 352.
9. Campbell, H. & E. Bramwell. 1900. Myasthenia gravis. Brain 23 : 277 336.
10. Schwab, R.S. & C.C. Leland. 1953. Sex and age in myasthenia gravis as critical factors in incidence and remission. J. Am. Med. Assoc. 153 : 1270 1273.
11. Somnier, F. 2005. Increasing incidence of late-onset anti-AChR antibody - seropositive myasthenia gravis. Neurology 65 : 928 930.
12. Matsuda, M. et al. 2005. Increase in incidence of elderly-onset patients with myasthenia gravis in Nagano Prefecture, Japan. Intern. Med. 44 : 572 527.
13. Casetta, I. et al. 2004. Incidence of myasthenia gravis in the province of Ferrara: a community-based study. Neuroepidemiology 23 : 281 284.
14. Poulas, K. et al. 2001. Epidemiology of seropositive myasthenia gravis in Greece. J. Neurol. Neurosurg. Psychiat. 71 : 352 356.
15. Walker, A. & T. Maltby. 1997. Ageing Europe. Open University Press. Buckingham and Philadelphia.
16. Jacobson, D.L. et al. 1997. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopath. 84 : 223 243.
17. Campbell, P.R. 1996. Population Projections for States by Age, Sex, Race, and Hispanic Origin: 1995 to 2025. U.S. Bureau of the Census.
18. Vincent, A. et al. 2003. Evidence of underdiagnosis of myasthenia gravis in older people. J. Neurol. Neurosurg. Psychiat. 74 : 1105 1108.
19. Limburg, P.C. et al. 1983. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part I. Relation to clinical parameters in 250 patients. J. Neurol. Sci. 58 : 37 370.
20. Mantegazza, R. et al. 1998. Anti AChR antibody: relevance to diagnosis and clinical aspects of myasthenia gravis. Ital. J. Neurol. Sci. 9 : 141 145.
21. Lindstrom, J.M. et al. 1976. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 26 : 1054 1059.
22. Evoli, A. et al. 2003. Clinical correlates with anti-MUSK antibodies in generalized seronegative myasthenia gravis. Brain 126 : 2304 2311.
23. Deymeer, F. et al. 2007. Clinical comparison of anti-MUSK-vs anti-AChR-positive and seronegative myasthenia gravis. Neurology 68 : 609 611.
24. Stickler, D.E., J.M. Massey & D.B. Sanders. MuSK-antibody positive myasthenia gravis: Clinical and electrodiagnostic patterns. Neurology 60 : 1978 1980.
25. Aarli, J.A. 1999. Late onset myasthenia gravis: A changing scene. Arch. Neurol. 56 : 25 27.
26. Gautel, M. et al. 1993. Identification of a major immunogenic region of titin. Neurology 43 : 1581 1585.
27. Boddaert, J. et al. 2004. Late-onset systemic lupus erythematosus: A personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine 83 : 348 359.
28. Turkcapar, N. et al. 2006. Late onset rheumatoid arthritis: clinical and laboratory comparisons with younger onset patients. Arch. Gerontol. Geriatr. 42 : 225 231.
29. Feltkamp, T.W. et al. 1974. Myasthenia gravis, autoantibodies and HLA antigens. Br. Med. J. 1 : 131 133.
30. Carlsson, B. et al. Different HLA DR-DQ associations in subgroups of idiopathic myasthenia gravis. Immunogenetics 31 : 285 290.
31. Giraud, P. et al. 2001. Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies. Neurology 57 : 1555 1560.
32. Keynes, G. 1949. The results of thymectomy in myasthenia gravis. BMJ 2 : 611 616.
33. Perlo, V.P., B. Arnason & B. Castleman. 1975. The thymus gland in elderly patients with myasthenia gravis. Neurology 25 : 294 295.
34. Gronseth, G.S. & R.J. Barohn. 2000. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review). Neurology 55 : 7 15.
35. Romi, F. et al. 2002. Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis. Eur. J. Neurol. 9 : 55 61.
36. Myking, A.M. et al. 1998. The histomorphology of the thymus in late onset, non-thymoma myasthenia gravis. Eur. J. Neurol. 5 : 401 405.